Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12079154 | 0.92 | — | — | |
| SCHEMBL1578618 | 0.89 | DUT (0.37) | DUT | |
| SCHEMBL662237 | 0.85 | DUT (0.36) | DUT | |
| SCHEMBL5856055 | 0.85 | DUT (0.33) | DUT | |
| SCHEMBL25755644 | 0.85 | DUT (0.33) | DUT | |
| SCHEMBL23727498 | 0.84 | DUT (0.35) | DUT | |
| SCHEMBL3650896 | 0.84 | DUT (0.35) | DUT | |
| SCHEMBL5356889 | 0.84 | DUT (0.35) | DUT | |
| SCHEMBL4053845 | 0.84 | DUT (0.35) | DUT | |
| SCHEMBL7588597 | 0.84 | DUT (0.35) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814462-B2 | Functionalized cyclic polymers and methods of preparing same | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2023-11-14 | — | — | US | claimed |
| US-20220056167-A1 | Functionalized Cyclic Polymers and Methods of Preparing Same | NATIONAL SCIENCE FOUNDATION | 2022-02-24 | — | — | US | claimed |
| US-20200388885-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH LIPO2F2 SALT-CONTAINING ELECTROLYTE FORMULATIONS | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| US-9546191-B1 | Palladium(II) complex for catalyzing sonogashira coupling reactions and a method thereof | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2017-01-17 | — | — | US | claimed |
| EP-0827423-B1 | FUNCTIONALIZED CHAIN EXTENDED INITIATORS FOR ANIONIC POLYMERIZATION | FMC CORP (US) | 2007-12-12 | — | — | EP | claimed |
| US-20060079099-A1 | Ultra low k plasma enhanced chemical vapor deposition processes using a single bifunctional precursor containing both a SiCOH matrix functionality and organic porogen functionality | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2006-04-13 | — | — | US | claimed |
| EP-4743465-A1 | BICYCLIC MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-20260116857-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFS | PARDES BIOSCIENCES INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4713096-A1 | CDK INHIBITOR COMPOUNDS | Aleksia Therapeutics, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20260049089-A1 | KRAS INHIBITOR COMPOUND | SHANGHAI APEIRON THERAPEUTICS COMPANY LIMITED (CN) | 2026-02-19 | — | — | US | disclosed |
| EP-4526298-A1 | PYRAZOLE DERIVATIVES AS STING AGONISTS | F. Hoffmann-La Roche AG (CH) | 2025-03-26 | — | — | EP | disclosed |
| US-20250074913-A1 | PYRAZOLE DERIVATIVES AS STING AGONISTS | HOFFMANN-LA ROCHE INC. (US) | 2025-03-06 | — | — | US | disclosed |
| US-20250026768-A1 | METHOD FOR THE SYNTHESIS OF AXIALLY CHIRAL ORGANOBORON COMPOUNDS | Laboratory for Synthetic Chemistry and Chemical Biology Limited (HK) | 2025-01-23 | — | — | US | disclosed |
| EP-0644187-A1 | Antimigraine cyclobutenedione derivatives of tryptamines | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-03-22 | — | — | EP | disclosed |
| US-5382592-A | Antimigraine cyclobutenedione derivatives of tryptamines | BRISTOL-MYERS SQUIBB COMPANY (US) | 1995-01-17 | — | — | US | disclosed |
| US-4931082-A | Triazole derivatives useful as plant growth regulating agents | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-06-05 | — | — | US | disclosed |
| US-4875922-A | FUNGICIDES; PLANT GROWTH REGULATORS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1989-10-24 | — | — | US | disclosed |
| EP-0272813-A2 | Pyrimidine derivatives | ZENECA LIMITED (GB) | 1988-06-29 | — | — | EP | disclosed |
| EP-0225739-A2 | 2-2-Dimethyl-3-hydroxy-3-propargyl-4-(1,2,4-triazole-1-yl -butane derivatives as plant growth regulators | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-06-16 | — | — | EP | disclosed |
| US-4515727-A | ANTIALLERGY, ANTINFLAMMATORY | SYNTEX (U.S.A.) INC. (US) | 1985-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260116857-A1 | INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFS | CTRC, CTRL, CTSL | DUT 3484/4885CA2 282/4885CA9 288/4885 |
| US-20260049089-A1 | KRAS INHIBITOR COMPOUND | KRAS, NRAS, HRAS | DUT 2707/4885CA2 1283/4885CA9 394/4885 |
| US-20250074913-A1 | PYRAZOLE DERIVATIVES AS STING AGONISTS | STING1, CGAS, MAVS | DUT 3911/4885CA2 3565/4885CA9 4631/4885 |
| US-20250026768-A1 | METHOD FOR THE SYNTHESIS OF AXIALLY CHIRAL ORGANOBORON COMPOUNDS | TBCB, CD79B, ZKSCAN2 | DUT 1749/4885CA2 1891/4885CA9 2569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.